Clinical Trial Update: Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the role of sleep apnea and sympathetic activity in patients with resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Obstructive Sleep Apnea
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Type 2 Diabetes, Diabetic Nephropathy | Phase 3 | Status: COMPLETED